Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-02

Clinical Trial Update: Safety and Effectiveness Study of a Fiber Supplement for Weight Loss [Phase 2]

View source ↗

Summary

A Phase 2 safety and effectiveness trial evaluating a fiber supplement for weight loss in individuals who are overweight or obese has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fiber supplement (fiber)

Snippet

Sponsor: Rush University Medical Center | Conditions: Overweight, Obesity | Phase 2 | Status: COMPLETED